ODTX (Odyssey Therapeutics) Interest Expense: $-0.01 Mil (TTM As of Mar. 2026)


ODTX Odyssey Therapeutics Inc ODTX
9 GF Score
Price $18.54
! 2 Warning Signs
View Full Analysis

What is Odyssey Therapeutics Interest Expense?

Odyssey Therapeutics ODTX -1.78% 9 Interest Expense is $-0.01 Mil as of Mar. 2026. GuruFocus rates ODTX with a GF Score™ of 9/100. The stock has 2 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Odyssey Therapeutics's interest expense for the three months ended in Mar. 2026 was $ -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.01 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Odyssey Therapeutics's Operating Income for the three months ended in Mar. 2026 was $ -39.67 Mil. Odyssey Therapeutics's Interest Expense for the three months ended in Mar. 2026 was $ -0.01 Mil. Odyssey Therapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Odyssey Therapeutics  (NAS:ODTX) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Odyssey Therapeutics's Interest Expense for the three months ended in Mar. 2026 was $-0.01 Mil. Its Operating Income for the three months ended in Mar. 2026 was $-39.67 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $20.75 Mil.

Odyssey Therapeutics's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Odyssey Therapeutics did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Odyssey Therapeutics Interest Expense Historical Data

* Premium members only.

The historical data trend for Odyssey Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Odyssey Therapeutics Interest Expense Chart

Odyssey Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Interest Expense
-0.29 -0.34 -0.02 -0.02

Odyssey Therapeutics Quarterly Data
Dec22 Dec23 Sep24 Dec24 Mar25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial 0.00 -0.00 -0.00 0.00 -0.01
ODTX
9GF Score
Odyssey Therapeutics Inc ODTX
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Odyssey Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.01 Mil mean?
Odyssey Therapeutics (ODTX) has a Interest Expense of $-0.01 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Odyssey Therapeutics and its competitors.
Is Odyssey Therapeutics' Interest Expense too high?
Odyssey Therapeutics' current Interest Expense is $-0.01 Mil. Overall, Odyssey Therapeutics has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Odyssey Therapeutics' Interest Expense compare to VOR and PHAT?
Odyssey Therapeutics' Interest Expense of $-0.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Odyssey Therapeutics and its competitors. Odyssey Therapeutics's current Interest Expense is $-0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Odyssey Therapeutics stock overvalued right now?
Odyssey Therapeutics (ODTX) has a current Interest Expense of $-0.01 Mil. The current Interest Expense is $-0.01 Mil. Odyssey Therapeutics' overall GF Score™ is 9/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Odyssey Therapeutics (ODTX), the current Interest Expense is $-0.01 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Odyssey Therapeutics Business Description

Address 51 Sleeper Street, Boston, MA, USA, 02210
Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.
9GF Score

Get the complete analysis for ODTX

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.54
Price